Posaconazole:Susc:Pt:Isolate:OrdQn:MIC

Known as: Posaconazol:Gevoeligheid:Moment:Isolaat:OrdinaalKwantitatief:Mininmaal inhiberende concentratie, Posaconazolo:Susc:Pt:Isolato:OrdQn:MIC, Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2018
012320072018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Mukormykosen werden durch Schimmelpilze der Ordnungen Mucorales und Entomophthorales verursacht. Die Sporen kommen ubiquitär vor… (More)
Is this relevant?
2016
2016
Solid-state NMR (ssNMR) spectroscopy has shown its indispensable capability of elucidating atomic level structures and… (More)
  • figure 2
  • figure 1
Is this relevant?
2014
2014
OBJECTIVES Scedosporium infections are associated with high therapeutic failure rates. Combination therapy may be an alternative… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2010
2010
Weltweit lässt sich eine Zunahme der Inzidenz invasiver Pilzinfektionen (IFIs) beobachten, die vor allem im Spitals-Setting mit… (More)
Is this relevant?
2010
2010
BACKGROUND Large randomized controlled trials have shown significant decreases in morbidity and mortality in leukaemia patients… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2010
2010
BACKGROUND Posaconazole is a novel antifungal drug for oral application intended especially for therapy of invasive mycoses. Due… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Posaconazole (Noxafil; Schering–Plough), a triazole antifungal drug, was approved by the US FDA in September 2006 for the… (More)
  • figure 1
Is this relevant?